Literature DB >> 15159322

Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.

Chanita Hughes Halbert1, Lari Wenzel, Caryn Lerman, Beth N Peshkin, Steven Narod, Alfred Marcus, Camille Corio, Tiffani Demarco, Scarlett Bellamy.   

Abstract

Although adjunctive educational and psychosocial programs are now being developed for BRCA1 and BRCA2 (BRCA1/2) mutation carriers, limited information is available about whether mutation carriers will want to receive such programs or about the characteristics of individuals who participate. The goals of the present study were to describe rates of completing a psychosocial telephone counseling (PTC) intervention that was offered to female BRCA1/2 mutation carriers and to identify sociodemographic and psychological factors associated with decisions to complete the intervention. Subjects were 66 BRCA1/2 mutation carriers who were randomized to receive a PTC intervention following receipt of genetic test results. Sociodemographic and psychological factors were evaluated before notification of assignment to the PTC intervention. Completion of the intervention was determined from study records. Overall, 75.8% of subjects completed the PTC intervention. Compared to unaffected subjects, those affected with breast and/or ovarian cancer were 76% less likely to complete the intervention [odds ratio (OR) = 0.24, 95% confidence interval (CI) = 0.06, 0.98, P = 0.05]. In addition, subjects with higher levels of cancer-specific distress [OR = 4.74, 95% CI = 1.02, 22.03, P = 0.05] and those with greater perceptions of social support [OR = 5.81, 95% CI = 1.29, 26.16, P = 0.02] were also most likely to complete the intervention. The results of this study suggest that while most BRCA1/2 mutation carriers are likely to complete an adjunctive psycho-educational program, personal history of cancer, cancer-specific distress, and perceptions of social support are likely to influence participation.

Entities:  

Mesh:

Year:  2004        PMID: 15159322

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

1.  The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience.

Authors:  Diana L Jones; Ellen W Clayton
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-15

2.  Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?

Authors:  Chanita Hughes Halbert; Jill E Stopfer; Jasmine McDonald; Benita Weathers; Aliya Collier; Andrea B Troxel; Susan Domchek
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

3.  Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.

Authors:  Kristi D Graves; Beth N Peshkin; Chanita H Halbert; Tiffani A DeMarco; Claudine Isaacs; Marc D Schwartz
Journal:  Breast Cancer Res Treat       Date:  2006-10-26       Impact factor: 4.872

Review 4.  Communication and technology in genetic counseling for familial cancer.

Authors:  H T Lynch; C Snyder; M Stacey; B Olson; S K Peterson; S Buxbaum; T Shaw; P M Lynch
Journal:  Clin Genet       Date:  2013-12-20       Impact factor: 4.438

5.  Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population.

Authors:  Suzanne C O'Neill; Chalanda Evans; Rebekah J Hamilton; Beth N Peshkin; Claudine Isaacs; Sue Friedman; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

6.  Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.

Authors:  Kristi D Graves; Lari Wenzel; Marc D Schwartz; George Luta; Paul Wileyto; Steven Narod; Beth N Peshkin; Alfred Marcus; David Cella; Susan Powell Emsbo; Denise Barnes; Chanita Hughes Halbert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

Review 7.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

8.  Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected].

Authors:  Edward L Nelson; Lari B Wenzel; Kathryn Osann; Aysun Dogan-Ates; Nissa Chantana; Astrid Reina-Patton; Amanda K Laust; Kevin P Nishimoto; Alexandra Chicz-DeMet; Nefertiti du Pont; Bradley J Monk
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

9.  Cognitive appraisals, coping and depressive symptoms in breast cancer patients.

Authors:  Silvia M Bigatti; Jennifer L Steiner; Kathy D Miller
Journal:  Stress Health       Date:  2012-08-10       Impact factor: 3.519

10.  Telephone interventions for symptom management in adults with cancer.

Authors:  Emma Ream; Amanda Euesden Hughes; Anna Cox; Katy Skarparis; Alison Richardson; Vibe H Pedersen; Theresa Wiseman; Angus Forbes; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.